Patents involving antibody medicines (antibody patents) are largely grouped into patents specified by antibody amino acid sequences (antibody sequence-based patents) and those not (non-sequence-based patents). Non-sequence-based patents have a broad scope and are thus very useful for protecting antibody medicines. Here, I investigate a recent trend in antibody patents characterized by an antibody-binding site in an antigen.
Case Study: Recently Granted Epitope-Based Antibody Patents in the United States, Europe and Japan
No Comments
Patent
- Enablement
- Fee Shifting
- Litigation
- Supreme Court’s Booking.com Ruling Signals Uptick in Registration of ‘Generic.com’ Marks
- Sixth Annual Firecracker 25: My Best Songs of All Time
- Other Barks & Bites for Friday, July 3: Busy Week for USPTO Announcements, New Vision Gaming Says PTAB Institution Process is Unconstitutional, Federal Circuit Affirms Invalidity of Enbrel Patent Claims
- A Dubious Decision: Eleventh Circuit Finds Scraping of Data from a Public Website Can Constitute Theft of Trade Secrets (Part I)
- Supreme Court Declines to Consider PTAB Authority to Overturn Article III Decisions
Recent Posts
- Supreme Court’s Booking.com Ruling Signals Uptick in Registration of ‘Generic.com’ Marks
- Sixth Annual Firecracker 25: My Best Songs of All Time
- Other Barks & Bites for Friday, July 3: Busy Week for USPTO Announcements, New Vision Gaming Says PTAB Institution Process is Unconstitutional, Federal Circuit Affirms Invalidity of Enbrel Patent Claims
- A Dubious Decision: Eleventh Circuit Finds Scraping of Data from a Public Website Can Constitute Theft of Trade Secrets (Part I)
- How to Plan an Outdoor Movie Night